Shen, Michelle
Liu, Shiqin
Toland, Angus
Hsu, En-Chi
Hartono, Alifiani B.
Alabi, Busola R.
Aslan, Merve
Nguyen, Holly M.
Sessions, Conner J.
Nolley, Rosalie
Shi, Chanjuan
Huang, Jiaoti http://orcid.org/0000-0003-1195-1998
Brooks, James D.
Corey, Eva http://orcid.org/0000-0002-9244-3807
Stoyanova, Tanya
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (R37CA240822-01A1, R01CA244281-01A1, P50CA092131, R01CA274978-01A1)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Defense (GRANT13686517)
U.S. Department of Health & Human Services | National Institutes of Health (CA229933, CA196387)
U.S. Department of Health & Human Services | National Institutes of Health
Article History
Received: 20 March 2023
Revised: 7 September 2023
Accepted: 19 September 2023
First Online: 5 October 2023
Competing interests
: TS is a consultant for Dren Bio, Inc. EC obtains funding from Genentech, Sanofi, AbbVie, Astra Zeneca, Foghorn Pharmaceuticals, Kronos Bio, MacroGenics, Janssen Research, Bayer Pharmaceuticals, Forma Pharmaceuticals, Gilead, Zenith Epigenetics and is a consultant of DotQuant.
: The collection of the tissues to construct the prostate cancer TMAs utilised for this study was reviewed and approved by the Research Compliance Office (IRB: 5628) at Stanford University. The collection of the lung cancer patient tissues utilised in this study was performed under informed consent and under the approved IRB protocol (IRB: 11977) at Stanford Cancer Institute. All methods were conducted under the guidance of ethical guidelines and relevant regulations from the Regional Ethics Committee.
: All authors gave written informed consent for the publication of the data.